- Eli Lilly ( NYSE: LLY) has actually gotten standard approval for its drug Retevmo for the treatment of a kind of thyroid cancer.
- The FDA authorized the item for the treatment of innovative or metastatic medullary thyroid cancer with a RET anomaly, as spotted
Source: Business Insider.